Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements

Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements

Saved in:
Bibliographic Details
Published in:Journal of managed care & specialty pharmacy Vol. 28; no. 5; pp. 518 - 527
Main Authors: Alexander, W. Allan, Jensen, Ivar, Hathway, Joanne, Srivastava, Krutika, Cyr, Philip, Sidonio, Robert F, Batt, Katharine
Format: Journal Article
Language:English
Published: 01-05-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2376-0540
2376-1032
DOI:10.18553/jmcp.2022.21197